We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Monthly information on share capital and company voting rights (Article 223-16 of General Regulation of the French financial markets authority)PARIS, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Listing...
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers)PARIS, 08...
Cellectis announces the drawdown of the third tranche of €5 million under the credit facility agreement entered with the European Investment Bank (EIB) NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE...
NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS) (the “Company”), a clinical-stage biotechnology company using its pioneering gene-editing platform...
Cellectis annonce le tirage de la troisième tranche de 5 millions d’euros dans le cadre du contrat de crédit conclu avec la Banque Européenne d’Investissement (BEI) NEW YORK , 10 déc. 2024...
Monthly information on share capital and company voting rights (Article 223-16 of General Regulation of the French financial markets authority)PARIS, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Listing...
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers)PARIS, 04...
Monthly information on share capital and company voting rights (Article 223-16 of General Regulation of the French financial markets authority)PARIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Listing...
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers)PARIS, 06 nov...
NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.212 | -12.1142857143 | 1.75 | 1.75 | 1.504 | 52528 | 1.56936819 | DE |
4 | 0.058 | 3.91891891892 | 1.48 | 2.08 | 1.442 | 97510 | 1.73203378 | DE |
12 | -0.232 | -13.1073446328 | 1.77 | 2.08 | 1.414 | 62105 | 1.73191249 | DE |
26 | -0.358 | -18.8818565401 | 1.896 | 2.17 | 1.414 | 50214 | 1.81887524 | DE |
52 | -0.882 | -36.4462809917 | 2.42 | 3.025 | 1.414 | 72625 | 2.19818556 | DE |
156 | -4.397 | -74.0859309183 | 5.935 | 6.045 | 0.888 | 158702 | 2.76979745 | DE |
260 | -14.922 | -90.6561360875 | 16.46 | 28.45 | 0.888 | 142105 | 6.39308975 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions